Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
.11 and Up!
»
NRGX Gene therapy
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by BooDog: [QB] Neurologix to Present at Roth Capital Partners 2008 OC Growth Conference Thursday February 14, 8:57 am ET Presentation to be Webcast on February 21, 2008 FORT LEE, N.J.--(BUSINESS WIRE)--Neurologix, Inc. (OTCBB: NRGX - News), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today that John Mordock, the company’s President and Chief Executive Officer, will present at the Roth Capital Partners 20th Annual OC Conference. The conference will be held February 18-21 at The Ritz-Carlton, Laguna Niguel in Dana Point, CA. ADVERTISEMENT Mr. Mordock will be making his presentation on February 21 at 09:30 am Pacific Time. The presentation will be broadcast live on the internet at http://www.wsw.com/webcast/roth16/nrgx/. Founded in 1984, Roth Capital Partners, LLC is an independent investment bank dedicated to emerging growth companies in the small and micro-cap market. For more information about the conference, see http://www.rothcp.com/main/Page.aspx?PageID=7010. About Neurologix Neurologix, Inc. (NRGX.OB) is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of life-altering gene transfer therapies for serious disorders of the brain and Central Nervous System (CNS). Neurologix’s therapeutic approach is built upon the groundbreaking research of its scientific founders and advisors, whose accomplishments have formed the foundation of gene therapy for neurological illnesses. Current company programs address such conditions as Parkinson’s disease, epilepsy and Huntington’s chorea, all of which are large markets not adequately served by current therapeutic options. For more information, please visit the Neurologix website at http://www.neurologix.net. Contact: Neurologix, Inc. Marc Panoff, 201-592-6451 Chief Financial Officer, Treasurer and Secretary marcpanoff*neurologix.net or Kureczka/Martin Associates Ellen M Martin, 510-832-2044 (Media) emm4*pacbell.net -------------------------------------------------------------------------------- Source: Neurologix, Inc. [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2